ImpactNRS

Impact NRS is a science-driven biotechnology company focused on developing natural, plant-based solutions to address global health challenges, particularly in metabolic and gut health. The company utilizes a proprietary "Reverse Pharmacology" platform to identify and validate bioactive compounds from natural sources that can modulate key biological pathways, such as endogenous GLP-1 secretion. Their lead programs target obesity and type 2 diabetes through innovative nutraceuticals and medical foods designed to mimic the effects of pharmaceutical interventions with a favorable safety profile. By bridging the gap between traditional nutrition and modern pharmacology, Impact NRS aims to provide sustainable and accessible health solutions for chronic metabolic conditions.